Traditional Chinese preparation for treating non-alcoholic fatty liver

Abstract

The invention discloses a traditional Chinese preparation for treating non-alcoholic fatty liver. Aiming at the fact considered by traditional Chinese medicine that liver depression and spleen deficiency, damp-heat, qi stagnation and blood stasis and phlegm and blood stasis are the pathogenesis of the non-alcoholic fatty liver, the traditional Chinese preparation is prepared into decoction through selecting traditional Chinese medicines which have the functions of soothing liver and tonifying qi, tonifying spleen and clearing damp and invigorating the circulation of blood and are radix bupleuri, bitter orange, rhizome cyperi, radix curcumae, rhizoma corydalis, dried orange peel, Tuckahoe, alisma orientale, rhizome atractylodis, plantain seed, semen cassiae, ligusticum wallichii, safflower, mastic, trogopterus dung and herba aristolochiae and then taken by patients. Clinical verification in Yinan People's Hospital of Shandong Province proves that the total effective rate of the traditional Chinese preparation is 94.0%, and the cure rate and the total effective rate of the traditional Chinese preparation are significantly superior to those of a control group, thus the traditional Chinese preparation disclosed by the invention is worth popularizing and applying in clinic.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a traditional Chinese medicinal preparation for treating non-alcoholic fatty liver disease. Background technique [0002] Nonalcoholic fatty liver disease refers to a clinicopathological syndrome characterized by diffuse hepatocellular bullous steatosis caused by the exclusion of alcohol and other definite liver damage factors. Although non-alcoholic fatty liver disease is generally considered to be a benign and static disease, it can develop into irreversible liver damage in a short period of time. The incidence of liver fibrosis is as high as 25%, and about 1.5% to 8%. Patients can progress to cirrhosis. In recent years, the incidence of non-alcoholic fatty liver disease has shown an obvious upward trend, and it has become the first major cause of chronic liver disease and abnormal liver function in developed countries. The prevalence of non-alcoholic fatty liver d...

AI Technical Summary

Problems solved by technology

[0003] In recent years, with the improvement of living standards and changes in lifestyle, the incidence of non-alcoholic fatty liver has been increa